News

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
In March, a German court sided with American pharmaceutical firm Moderna in its claim that BioNTech and Pfizer had broken one of its patents in making its Covid-19 vaccine. Provided by SyndiGate Media ...
Apple and Trump detail $100 billion U.S. spending expansion: Here's what to know Brandon Blackstock, Kelly Clarkson's ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain’s GSK and Germany’s CureVac US$740 ...
The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...
When COVID-19 cases were surging, Dr. David Wohl saw patients “hungry for air” fill UNC hospital wards. What most saved lives ...
News of a trade secrets leak involving TSMC and an action in Japan against AI startup Perplexity were also among the top ...
In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...
A research project at Emory University is among the 22 grants and contracts that are being cancelled as the U.S. Department ...
This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...
Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...